What's inside Elon's building in Memphis will shock you
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
| Open | 165.48 | Prev Close | 164.74 |
| High | 167.62 | Low | 164.79 |
| Volume | 8,928,229 | Volume (Avg) | 8,268 |
| 52 Week High | 169.99 | 52 Week Low | 138.38 |
| Market Cap | 403B | PE Ratio | 17.90 |
General
| Name | Johnson & Johnson |
| Ticker | JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 138,100 |
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Highlights
| Analyst Target | 176.45 |
| Market Cap | 402,987,400,000 |
| PE Ratio | 17.90 |
| PEG Ratio | 1.02 |
| EBITDA | 30,254,000,128 |
Valuation
| Trailing PE | 17.92 |
| Forward PE | 15.58 |
| Price/Sales (Trailing 12 Mt.) | 4.45 |
| Price/Book (Most Recent Quarter) | 5.14 |
Technicals
| Beta | 0.40 |
| 52 Week High | 169.99 |
| 52 Week Low | 138.38 |
| 50 Day Average | 6.28% |
| 200 Day Average | 7.55% |
Dividend
Johnson & Johnson pays out a dividend of $5.06 per share, with a dividend yield of 3.03%.
JNJ's next dividend payment will be made to shareholders on September 9, 2025.
They pay out 84.80% of their earnings out as a dividend.
Recent Dividends
| Sep 9, 2025 | $1.30 |
| Jun 10, 2025 | $1.30 |
| Mar 4, 2025 | $1.24 |
| Dec 10, 2024 | $1.24 |
| Sep 10, 2024 | $1.24 |
| Jun 4, 2024 | $1.24 |
| Mar 5, 2024 | $1.19 |
| Dec 5, 2023 | $1.19 |
| Sep 7, 2023 | $1.19 |
Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD
Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.
Trump seeks to fire official overseeing jobs data after weak employment report
WASHINGTON (AP) — President Donald Trump on Friday called for the firing of the head of the agency that produces the monthly jobs figures after a report showed hiring and was much weaker in May and June than previously reported.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Cathie Wood's Wednesday Moves: Ark Dumps Bitcoin-Heavy Block Again, Doubles Down On AMD's AI Chip Rally (CORRECTED)
Editor’s Note: The headline has been corrected from the original version to ensure accuracy and clarity
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert
Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.
Apple Surges After-Hours As Q3 Earnings Crush Estimates, iPhone And Services Lead Growth
Apple Inc. shares jumped 2.42% in after-hours trading on Thursday, reaching $212.59, after the iPhone maker delivered third-quarter results that significantly exceeded Wall Street expectations.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Jim Cramer: This Consumer Defensive Stock Is 'Pretty Expensive'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said that although CoreWeave, Inc. (NASDAQ:CRWV) is good, but Nvidia (NASDAQ:
Ranchers say expanding herds to take advantage of record retail beef prices isn't so simple
MINNEAPOLIS (AP) — In a period when retail beef prices are at an all-time high and consumers are still willing to pay, South Dakota rancher Calli Williams would love to cash in. But it's not so simple.
Leaked Memo Reveals AI's Next Land Grab - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Pope Leo XIV surprises Catholic youth festival with unexpected popemobile salute
VATICAN CITY (AP) — surprised tens of thousands of young Catholics on Tuesday and showed up unexpectedly at a Holy Year welcome ceremony, thrilling the kids and receiving a rock star’s welcome in the first big youth event of his pontificate.
Adam Sandler Says He 'Didn't Want To Bug' Eminem For Happy Gilmore 2 Cameo, But The Rap Icon Said Yes Anyway: Here's How It's Faring For Netflix
Adam Sandler says he hesitated to ask Eminem for a Happy Gilmore 2 cameo, but the rapper agreed—the film is now Netflix's biggest US opening.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Trump Is Yet To Sign A Trade Deal With Over 85% Of Humanity — Here Are The Major Countries That Are Yet To Sign
Trump gave a hard deadline for countries that haven't signed a trade deal to start paying tariffs by Aug 1. Most of the world is yet to sign.
What's Going On With Builders FirstSource Stock Today?
Builders FirstSource beat Q2 EPS but missed on sales, cut its FY25 outlook, and saw margins shrink, sending shares down over 3%.
$5 Stock Building Nvidia's AI Servers - Ad
Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.
Asian shares are mixed after US stocks fall on weakened hopes for a September interest rate cut
MANILA, Philippines (AP) — Asian shares were mixed on Thursday after most , as doubts rose on Wall Street about whether the Federal Reserve will deliver economy-juicing cuts to interest rates by September.
Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?
Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Rocket Companies Stock Blasts Off On Q2 Results: Here Are The Highlights
Rocket Companies beat Street estimates in the second quarter. Here are the highlights.
Meta's AI Firepower Could Ignite Magnificent Seven ETFs
Meta Platformsis expected to report its 11th consecutive revenue beat, attracting attention from stock pickers and ETF investors due to its growing presence in Big Tech and AI-themed ETFs.
Hidden $5 AI Manufacturer Revealed - Ad
The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.
Peter Schiff Slams Fed's Blind Spot: Jerome Powell 'Looking Through' Soaring Inflation While Policy Remains 'Far Too Loose'
Economist Peter Schiff is criticizing the Federal Reserve on inflation, arguing that the central bank is underestimating persistent price pressures.
Trump to visit Federal Reserve headquarters as feud with its chair continues
WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Align Technology Stock Tumbles Wednesday: What's Going On?
Align Technology shares are tumbling in Wednesday's after-hours session after the company reported worse-than-expected results for the second quarter and issued soft guidance.
Jack Dorsey's Block, With Over $1 Billion In Bitcoin Holdings, Set To Join S&P 500 — Shares Pop 8% In Overnight Trading
Block, Inc. (NYSE:XYZ) shares are soaring in overnight trading on Sunday ahead of the S&P 500 debut of the Jack Dorsey-founded fintech company.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Pilot arrested on child sex abuse material charges after landing at San Francisco airport
SAN FRANCISCO (AP) — A pilot was arrested aboard a Delta Air Lines flight and federal agents took him into custody from the cockpit after the plane landed at San Francisco International Airport.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
Western Digital Stock Climbs As Q4 Revenue, EPS Top Estimates Driven By Strong Cloud Momentum
Western Digital shares are rising in extended trading Wednesday after the company reported better-than-expected financial results and issued strong guidance.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
AMD Stock Is Sliding Tuesday: What's Driving The Action?
Shares of Advanced Micro Devices are trading lower Tuesday afternoon. The stock is caught in a broader downturn affecting the semiconductor industry.
BYD Surpasses Tesla In Fortune Global 500 List Amid Sales Slump For Elon Musk's EV Giant
BYD surpassed Tesla on Fortune Global 500 list, with BYD at #92 and Tesla at #102. BYD's growth in global markets may be a factor.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Want To Bet Bigger On UnitedHealth? Now There's A Cheaper Way
New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.